Related Experiment Videos
Management of acute myocardial infarction in the elderly
1Division of Geriatrics and Cardiology, Miriam Hospital, Brown University, Providence, Rhode Island, USA.
Insights
Myocardial infarction (MI) risk increases with age due to cardiovascular changes. Aggressive therapeutic strategies, including invasive and pharmaceutical options, are warranted for older MI patients, as age is not a contraindication to treatment.
Area of Science:
- Cardiology
- Gerontology
- Internal Medicine
Background:
- Aging is associated with physiological and morphological changes that increase cardiovascular instability.
- The incidence of myocardial infarction (MI), morbidity, and mortality significantly rise with advancing age.
- Older adults with MI may benefit substantially from tailored therapeutic interventions.
Purpose of the Study:
- To review age-related cardiovascular changes contributing to increased MI incidence.
- To discuss the benefits of aggressive therapeutic strategies in elderly MI patients.
- To outline age-specific management for peri-infarction complications in older adults.
Main Methods:
- Review of age-related cardiovascular changes affecting MI risk.
- Analysis of invasive (angioplasty) and pharmaceutical treatment options for MI.
- Examination of age-specific strategies for managing MI complications.
Main Results:
- Age-related cardiovascular changes predispose older adults to MI.
- Age is not a contraindication for aggressive MI therapy.
- Older MI patients face significant peri-infarction complications like heart failure and shock.
Conclusions:
- Older adults experience a higher incidence and mortality from MI due to aging-related cardiovascular changes.
- Aggressive therapeutic strategies, including angioplasty and various pharmaceuticals, are recommended for elderly patients with MI.
- Age-specific management plans are crucial for addressing common and severe complications in older MI patients.
Abstract:
The prevalence of myocardial infarction (MI) is high among the elderly population. Many of the physiological and morphological changes attributable to 'normal' aging predispose older adults to cardiovascular instability. The incidence of both MIs and their associated morbidity and mortality increase with aging. Older MI patients may therefore derive substantial benefit from appropriately selected therapeutic intervention. In fact, given the high morbidity and mortality associated with MI in the elderly, aggressive therapeutic strategies may be particularly warranted. There are a number of age-related cardiovascular changes that contribute to the increasing incidence of MI as adults age. However, age itself is not a contraindication to aggressive therapy. Common MI management options include invasive and pharmaceutical strategies. The relative advantages of angioplasty and thrombolytics must be considered. Other drugs used in the treatment of MI include beta-blockers, ACE inhibitors, nitrates, aspirin, anticoagulants, magnesium, antiarrhythmics and calcium antagonists. Significant peri-infarction complications, including heart failure, hypotension, arrhythmias, myocardial rupture and cardiogenic shock, often occur in older adults. Age-specific management strategies for these complications are reviewed.